Related Experiment Video

Updated: Apr 11, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.7K

Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs

Antonello Di Paolo1, Marialuisa Polillo, Marianna Lastella

  • 1University of Pisa, Department of Clinical and Experimental Medicine, Via Roma 55, 56126 Pisa , Italy +39 050 2218755 ; +39 050 2218758 ; antonello.dipaolo@med.unipi.it.

Expert Opinion on Drug Metabolism & Toxicology
|June 4, 2015
PubMed
Abstract

Insights

Pharmacogenetic profiling is crucial for personalized cancer therapies, guiding treatment selection based on genetic markers. Challenges include choosing analysis strategies and ensuring result reproducibility for clinical translation.

Area of Science:

  • Oncology
  • Pharmacogenomics
  • Translational Research

Background:

  • Molecular and genetic analyses identify markers for patient-centered cancer therapies, predicting drug efficacy and tolerability.
  • Current treatments often combine synergistic drugs targeting different pathways, necessitating comprehensive pharmacogenetic profiling.
  • Pharmacogenetic profiling of tumors and patients presents challenges for translational study design.

Purpose of the Study:

  • To review techniques for stratifying oncology patients based on pharmacogenetic profiles.
  • To discuss the advantages and limitations of methodologies for tailoring antineoplastic treatments.
  • To address challenges in pharmacogenetic profiling for personalized cancer care.

Main Methods:

  • Review of various techniques for pharmacogenetic profiling in oncology.
  • Discussion of patient stratification strategies.
  • Analysis of methods for tailoring antineoplastic treatments.

Main Results:

  • Identification of diverse techniques for individual pharmacogenetic profiling.
  • Evaluation of the benefits and drawbacks of current methodologies.
  • Highlighting the complexity of choosing appropriate genetic analysis strategies.

Conclusions:

  • Rapid advancements in genetic analysis necessitate careful selection of strategies, from gene candidate to next-generation sequencing.
  • Replication of study results for validation poses a significant future obstacle.
  • The evolving landscape offers new opportunities to overcome previous limitations in translating research to clinical practice.
Keywords:
combination therapiesnext-generation sequencingoncologypharmacogenetic profiling

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.9K

Related Concept Videos

Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
148
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
174
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
125
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
91
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
110